Work

CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network

Year: 2011

Type: article

Abstract: The slow rate at which pharmacogenetic tests are being adopted in clinical practice is partly due to the lack of specific guidelines on how to adjust medications on the basis of the genetic test results. One of the goals of the Clinical Pharmacogenetics Implementation Consortium (CPIC) of the National Institutes of Health's Pharmacogenomics Research Network (http://www.pgrn.org) and the Pharmacogenomics Knowledge Base (PharmGKB, http://www.pharmgkb.org) is to provide peer-reviewed, updated, evidence-based, freely accessible guidelines for gene/drug pairs. These guidelines will facilitate the translation of pharmacogenomic knowledge from bench to bedside. Clinical Pharmacology & Therapeutics (2011) 89 3, 464–467. doi:10.1038/clpt.2010.279

Source: Clinical Pharmacology & Therapeutics

DOI: 10.1038/clpt.2010.279

Authors: M V Relling, T E Klein

Institutions: St. Jude Children's Research Hospital, Stanford University

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute, National Institute of General Medical Sciences, National Institute of Child Health and Human Development